Combating the Growing Burden of Diabetes in India. India is home to over 77 million people living with diabetes, making major contributor to the global diabetes epidemic. By 2030, this number is expected to surge to 101 million. Furthermore, a staggering 40% of Indians with diabetes remain undiagnosed. At aretamedicare Pharmaceuticals, we are dedicated to addressing this pressing health concern through our comprehensive anti-diabetes portfolio.

Diabetes Product List

Sr.No.	Product/Brand Name	Composition
1.	ARETAMET -G1	Glimipiride 1 mg +Metformin (SR) 500 mg Tablets
2.	ARETAMET -G2	Glimipiride 2 mg +Metformin (SR) 500 mg Tablets
3.	ARETAMET-PG1	Glimipiride 1 mg + Metformin (SR) 500 mg + Pioglitazone 15 mg Tablets
4.	ARETAMET-PG2	Glimipiride 2 mg +Metformin (SR) 500 mg + Pioglitazone 15 mg Tablets